Indivior

Indivior

A global pharmaceutical company working to help change patients’ lives by pioneering life-transforming treatment for addiction and other serious mental illnesses. Learn more

Launch date
Employees
Market cap
CAD1.7b
Enterprise valuation
CAD1.6b (Public information from Sep 2024)
Bon Air Virginia (HQ)

Financials

Estimates*

Edit
Revenues, earnings & profits over time
USD2020202120222023202420252026
Revenues647m791m901m1.1b1.2b1.2b1.4b
% growth(18 %)22 %14 %21 %8 %4 %10 %
EBITDA(121m)207m(51.0m)62.0m340m381m464m
% EBITDA margin(19 %)26 %(6 %)6 %29 %31 %34 %
Profit(148m)205m(53.0m)2.0m116m260m373m
% profit margin(23 %)26 %(6 %)-10 %21 %27 %
EV / revenue0.8x2.0x2.8x1.8x1.2x0.9x0.7x
EV / EBITDA-4.3x7.7x-49.3x32.0x4.1x3.0x1.9x
R&D budget40.0m52.0m72.0m106m---
R&D % of revenue6 %7 %8 %10 %---

Source: Dealroom estimates

  • Edit
DateInvestorsAmountRound
N/A

N/A

IPO
*

N/A

Post IPO Equity
Total Funding-

Recent News about Indivior

Edit
More about Indiviorinfo icon
Edit

Indivior is a global pharmaceutical company dedicated to developing medicines that treat substance use disorders and serious mental illnesses. The company operates in the healthcare sector, focusing on patients who suffer from addiction and mental health issues. Indivior's business model revolves around research and development of innovative treatments, which are then brought to market to improve patient outcomes. The company generates revenue through the sale of its pharmaceutical products, which are prescribed by healthcare professionals and used by patients worldwide. Indivior's commitment to patient safety and high-quality treatments is evident in its rigorous monitoring and reporting systems for product concerns and adverse events. By addressing critical healthcare needs, Indivior aims to create sustainable value and make a significant impact on global health.

Keywords: pharmaceutical, addiction treatment, mental health, substance use disorders, patient safety, innovative medicines, global healthcare, research and development, sustainable value, healthcare professionals.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Indivior

Edit
Opiant
ACQUISITION by Indivior Nov 2022